piperacillin has been researched along with Primary Peritonitis in 60 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (25.00) | 18.7374 |
| 1990's | 14 (23.33) | 18.2507 |
| 2000's | 17 (28.33) | 29.6817 |
| 2010's | 12 (20.00) | 24.3611 |
| 2020's | 2 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dupont, H; Eloy, P; Esposito-Farèse, M; Grall, N; Lasocki, S; Montravers, P; Seguin, P; Veber, B; Weiss, E | 1 |
| Almind, SR; Andreasen, MR; Frimodt-Møller, N; Hansen, KH; Hertz, FB; Jelsbak, L; Nielsen, KL; Schønning, K | 1 |
| Ledger, TS | 1 |
| Arnaud, A; Costet, N; Donnio, PY; Engrand, C; Habonimana, E; Nardi, N; Taleb, M; Tattevin, P; Wodey, E | 1 |
| Bandettini, R; Buffa, P; Castagnola, E; Caviglia, I; Ciucci, A; Ginocchio, F; Guida, E; Haupt, R; Loy, A; Masa, DL; Mattioli, G; Perotti, M; Pini Prato, A | 1 |
| Belghiti, J; Bert, F; Dondero, F; Durand, F; Larroque, B; Moreau, R; Nicolas-Chanoine, MH; Paugam-Burtz, C | 1 |
| Burnweit, C; Diana-Zerpa, J; Knight, C; Malvezzi, L; Nazarey, PP; Pasaron, R; Stylianos, S; Stylianos, V; Triana, J; Velis, E | 1 |
| Awais, M; Rehman, A; Ul-Ain Baloch, N | 1 |
| Beerle, C; Breitenstein, S; Gelpke, H; Staerkle, RF | 1 |
| Gong, R; Huang, X; Li, C; Liu, J; Liu, Y; Xu, H | 1 |
| Adelman, MH; Cohn, SM; Gilliland-Johnson, KK; Paladino, JA | 1 |
| Cortés, C; Giménez, L; Pueyo, A; Ramos, A | 1 |
| Cavallo, JD; Chomarat, M; Dubreuil, L; Joly-Guillou, ML; Kempf, M; Maugein, J; Muller-Serieys, C; Roussel-Delvallez, M | 1 |
| Homann, C; Knudsen, JD; Moser, C; Novovic, S; Olsen, H; Semb, S | 1 |
| Couet, W; Grégoire, N; Marliat, M; Mimoz, O; Nordmann, P; Poirel, L | 1 |
| Carides, A; Choe, KA; Christou, NV; Dellinger, EP; Fernandez, A; Malafaia, O; Rotstein, OD; Satishchandran, V; Solomkin, JS; Tellado, JM; Teppler, H; Yellin, AE | 1 |
| Faltýn, J; Lochmann, O; Vyhnánek, F | 1 |
| Zaĭtsev, AA | 1 |
| Cirioni, O; D'Amato, G; Del Prete, MS; Ghiselli, R; Giacometti, A; Kamysz, W; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Viticchi, C; łLukasiak, J | 1 |
| Cirioni, O; D'Amato, G; Ghiselli, R; Giacometti, A; Kamysz, W; Lukasiak, J; Mocchegiani, F; Naldoski, P; Orlando, F; Saba, V; Scalise, G; Silvestri, C; Sisti, V | 1 |
| Kotapati, S; Kuti, JL; Nicolau, DP | 1 |
| Bette, M; Menendez, S; Mutters, R; Nüsing, RM; Schulz, S; Zamora, ZB | 1 |
| Asperger, W; Chan, CY; Dela Pena, AS; DiNubile, MJ; Giezek, H; Kafka, R; Köckerling, F; Raz, R; Shivaprakash, M; Vrijens, F; Warren, B | 1 |
| Barra, D; Bozzi, A; Cirioni, O; Di Giulio, A; Ghiselli, R; Giacometti, A; Luzi, C; Mangoni, ML; Mocchegiani, F; Orlando, F; Rinaldi, AC; Saba, V; Scalise, G; Silvestri, C | 1 |
| Abramson, MA; Jensen, EH; Namias, N; Solomkin, JS; Tomassini, JE | 1 |
| Cirioni, O; Di Matteo, F; Ghiselli, R; Giacometti, A; Kamysz, E; Kamysz, W; Mocchegiani, F; Orlando, F; Riva, A; Rocchi, M; Saba, V; Scalise, G; Silvestri, C | 1 |
| Abbruzzetti, A; Cirioni, O; Di Matteo, F; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Silvestri, C | 1 |
| Cars, O; Gierup, J; Linglöf, T; Nordbring, F | 1 |
| Minaguchi, H; Ohtsuka, T; Uemura, T | 1 |
| Wittmann, DH | 1 |
| Kager, L; Nord, CE | 1 |
| Mandell, GL | 1 |
| Stille, W | 1 |
| Kaminski, ZC; Lazaro, EJ; Najem, AZ; Spillert, CR | 1 |
| Aldridge, KE | 1 |
| Grundel, E; Vestweber, KH | 1 |
| Hirayama, T; Iwai, S; Mashita, K; Matsuno, S; Nakagawa, Y; Otsuka, K; Rikiyama, T; Shinagawa, N; Tanaka, T; Yura, J | 1 |
| Barie, PS; Cheadle, WG; Fink, MP; Garber, GE; Hebert, JC; Laverdiere, M; Polk, HC; Wilson, SE | 1 |
| Dequiedt, P; Fruchart, A; Pagniez, D | 1 |
| Arguedas, A; Corrales, JC; Herrera, M; Loaiza, C; Mohs, E; Sifuentes-Osornio, J | 1 |
| Gel'fand, BR; Gel'fand, EB; Lapshina, IIu; Topazova, EN | 1 |
| Klimonova, NV; Lobakov, AI; Nasonov, VN; Savitskaia, KI; Savov, AM | 1 |
| Ambrosetti, P; Aymon, D; Bille, J; Chiolero, R; Cometta, A; Glauser, MP; Harbarth, S; Huber, O; Jaccard, C; Lew, D; Praz, G; Ricou, B; Romand, J; Schneider, R; Troillet, N; Zanetti, G | 1 |
| Cederberg, A; Forssell, H; Ohlin, B; Solhaug, JH; Tveit, E | 1 |
| Jacobs, S; Morais, C; Sobki, S; Tariq, M | 1 |
| Carbon, C; Carlet, J; Dupont, H | 1 |
| Androulakakis, E; Dimitriou, L; Kafetzis, DA; Lebesii, E; Maltezou, HC; Nikolaidis, P | 1 |
| Bailie, GR; Crawford, TL; Diaz-Buxo, JA | 1 |
| Berry, V; Mizen, L; Woodnutt, G | 1 |
| Alhava, EM; Huttunen, R; Karjalainen, K; Lahtinen, J; Miettinen, P; Paakkonen, M; Silvola, H; Viitanen, J | 1 |
| Tzamaloukas, AH | 1 |
| Debruyne, D; Hurault De Ligny, B; Moulin, M; Ryckelynck, JP | 1 |
| Hashimoto, I; Maezawa, I; Matsushita, T; Nakamura, T; Ohshima, S; Okuno, S; Sawada, Y; Yamaguchi, T | 1 |
| Eustratiades, N; Laschon, MC; Laurent, J; Malbruny, B; Morel, C; Ravasse, P; Vergnaud, M | 1 |
| Aoki, A; Gato, S; Saigusa, M; Shiritani, Y; Tsuji, A; Yamaji, S; Yokoiyama, S | 1 |
| Brendel, W; Hart, H; Seifert, J | 2 |
| Andreu, M; Campo, R; Force, L; Sola, R | 1 |
| Calia, FM; Johnson, DE; Thompson, B | 1 |
2 review(s) available for piperacillin and Primary Peritonitis
| Article | Year |
|---|---|
Severe ovarian hyperstimulation syndrome complicated by Stenotrophomonas maltophilia peritonitis: a case report and literature review.
Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Female; Gram-Negative Bacterial Infections; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Stenotrophomonas maltophilia; Treatment Outcome | 2015 |
Anaerobes in polymicrobial surgical infections: incidence, pathogenicity, and antimicrobial resistance.
Topics: Abdominal Abscess; Bacteremia; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; beta-Lactamase Inhibitors; beta-Lactamases; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Incidence; Penicillanic Acid; Peritonitis; Piperacillin; Surgical Wound Infection; Tazobactam; Virulence | 1994 |
17 trial(s) available for piperacillin and Primary Peritonitis
| Article | Year |
|---|---|
Risk factors for therapeutic failure in the management of post-operative peritonitis: a post hoc analysis of the DURAPOP trial.
Topics: Anti-Bacterial Agents; Humans; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Risk Factors | 2021 |
Pharmacoeconomics of ciprofloxacin plus metronidazole vs. piperacillin-tazobactam for complicated intra-abdominal infections.
Topics: Abdominal Abscess; Adult; Aged; Anti-Bacterial Agents; Appendicitis; Ciprofloxacin; Cost-Benefit Analysis; Double-Blind Method; Drug Therapy, Combination; Economics, Pharmaceutical; Female; Humans; Male; Metronidazole; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome | 2008 |
Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Digestive System Surgical Procedures; Double-Blind Method; Drug Therapy, Combination; Ertapenem; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitalization; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Research Design; Treatment Outcome | 2003 |
[Carbapenem antibiotic ertapenem in the treatment of extrahospital intraabdominal infections].
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome | 2003 |
Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention.
Topics: Abdomen; Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Diarrhea; Ertapenem; Escherichia coli Infections; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome | 2006 |
Randomized, multicenter, double-blind study of efficacy, safety, and tolerability of intravenous ertapenem versus piperacillin/tazobactam in treatment of complicated intra-abdominal infections in hospitalized adults.
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacterial Infections; Bacteroides; beta-Lactams; Double-Blind Method; Ertapenem; Escherichia coli; Female; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2007 |
A clinical evaluation of piperacillin in intra-abdominal infections.
Topics: Adult; Aged; Bacterial Infections; Cholangitis; Cholecystitis; Clinical Trials as Topic; Humans; Intestinal Diseases; Microbial Sensitivity Tests; Middle Aged; Peritonitis; Piperacillin; Postoperative Complications; Premedication; Surgical Wound Infection | 1984 |
Efficacy and safety of piperacillin/tazobactam in intra-abdominal infections.
Topics: Abdomen; Abdominal Abscess; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Europe; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam | 1994 |
[Bacteriological and clinical evaluation tazobactam/piperacillin in infectious diseases in surgical field].
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Cholangitis; Cholecystitis; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Surgical Wound Infection; Tazobactam | 1995 |
Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The Piperacillin/Tazobactam Intra-Abdominal Infection Study Group.
Topics: Abdomen; Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Appendicitis; Bacterial Infections; beta-Lactamase Inhibitors; Cholangitis; Cholecystitis; Clindamycin; Combined Modality Therapy; Diverticulitis; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam | 1993 |
[Piperacillin/tazobactam in the treatment of abdominal sepsis in patients with peritonitis].
Topics: Abdominal Abscess; Adult; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis | 1997 |
[Use of piperacillin-tazobactam in abdominal surgery].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamase Inhibitors; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Penicillanic Acid; Penicillins; Peritonitis; Piperacillin; Sepsis; Surgical Wound Infection; Tazobactam; Treatment Outcome | 1997 |
Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis.
Topics: Acute Disease; Adult; Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Pneumonia; Prospective Studies; Pseudomonas Infections; Tazobactam | 1998 |
Piperacillin/tazobactam compared with cefuroxime/ metronidazole in the treatment of intra-abdominal infections.
Topics: Abdominal Abscess; Appendicitis; Bacterial Infections; beta-Lactamase Inhibitors; Cefuroxime; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Intestinal Perforation; Male; Metronidazole; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Rupture, Spontaneous; Surgical Wound Infection; Tazobactam | 1999 |
Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Penicillanic Acid; Penicillins; Peritonitis; Piperacillin; Tazobactam; Treatment Outcome | 2000 |
Piperacillin/Tazobactam versus cefotaxime plus metronidazole for treatment of children with intra-abdominal infections requiring surgery.
Topics: Abdominal Abscess; Adolescent; Appendicitis; Bacterial Infections; Cefotaxime; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Intestinal Perforation; Male; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome | 2001 |
Piperacillin compared with cefuroxime plus metronidazole in diffuse peritonitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Cefuroxime; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Peritonitis; Piperacillin | 1991 |
41 other study(ies) available for piperacillin and Primary Peritonitis
| Article | Year |
|---|---|
Efficacy of piperacillin-tazobactam and cefotaxime against Escherichia coli hyperproducing TEM-1 in a mouse peritonitis infection model.
Topics: Animals; Anti-Bacterial Agents; Antigens, CD; beta-Lactamases; Cefotaxime; Escherichia coli; Escherichia coli Infections; Mice; Microbial Sensitivity Tests; Neoplasm Proteins; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam | 2022 |
Topics: Amoxicillin; Anti-Bacterial Agents; Clavulanic Acid; Clindamycin; Diagnosis, Differential; Female; Humans; Middle Aged; Penicillanic Acid; Penicillin G; Peritonitis; Piperacillin; Streptococcal Infections; Streptococcus pyogenes; Tazobactam; Treatment Outcome | 2018 |
Simplification of first-line antibacterial regimen for complicated appendicitis in children is associated with better adherence to guidelines and reduced use of antibiotics.
Topics: Adolescent; Anti-Bacterial Agents; Appendicitis; Cefotaxime; Child; Drug Therapy, Combination; Female; Gentamicins; Guideline Adherence; Humans; Length of Stay; Male; Metronidazole; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Practice Guidelines as Topic; Retrospective Studies | 2018 |
Susceptibility to antibiotics of aerobic bacteria isolated from community acquired secondary peritonitis in children: therapeutic guidelines might not always fit with and everyday experience.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Gentamicins; Hospitals, Pediatric; Humans; Italy; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Sulbactam; Thienamycins | 2013 |
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial; End Stage Liver Disease; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Preoperative Period; Risk Factors; Severity of Illness Index | 2014 |
Treatment of suspected acute perforated appendicitis with antibiotics and interval appendectomy.
Topics: Abdominal Abscess; Abdominal Pain; Anti-Bacterial Agents; Appendectomy; Appendicitis; Child; Critical Pathways; Drug Administration Schedule; Drug Combinations; Fever; Humans; Intestinal Perforation; Patient Readmission; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Suction; Time Factors; Treatment Outcome | 2014 |
Complicated acute appendicitis presenting as a rapidly progressive soft tissue infection of the abdominal wall: a case report.
Topics: Abdominal Pain; Abdominal Wall; Anti-Bacterial Agents; Appendectomy; Appendicitis; Emphysema; Escherichia coli Infections; Female; Humans; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Reoperation; Soft Tissue Infections; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
[Clinical analysis for patients with continuous ambulatory peritoneal dialysis associated peritonitis].
Topics: Abdominal Pain; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Candidiasis; Catheters; Diarrhea; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mycoses; Penicillanic Acid; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Recurrence; Retrospective Studies; Staphylococcus epidermidis; Staphylococcus haemolyticus; Vomiting | 2016 |
[Appendicitis in an HIV-positive South American immigrant].
Topics: Abdominal Abscess; Albendazole; Animals; Anthelmintics; Anti-HIV Agents; Appendectomy; Appendicitis; Ascariasis; Ascaris lumbricoides; Bacteroides fragilis; Bacteroides Infections; Combined Modality Therapy; Emigrants and Immigrants; Escherichia coli Infections; Female; HIV Infections; Humans; Immunocompromised Host; Intestinal Diseases, Parasitic; Jejunum; Paraguay; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Young Adult | 2010 |
Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study.
Topics: Anti-Bacterial Agents; Bacteremia; France; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Thienamycins; Wound Infection | 2010 |
First-line treatment with cephalosporins in spontaneous bacterial peritonitis provides poor antibiotic coverage.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ascitic Fluid; Cephalosporins; Denmark; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Kaplan-Meier Estimate; Liver Cirrhosis; Male; Meropenem; Middle Aged; Mycoses; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Thienamycins | 2012 |
Broad-spectrum β-lactam antibiotics for treating experimental peritonitis in mice due to Klebsiella pneumoniae producing the carbapenemase OXA-48.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Ertapenem; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lethal Dose 50; Mice; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Survival Rate | 2012 |
[Initial empirical antimicrobial therapy with piperacillin/tazobactam in intra-abdominal infections due to perforation of the large intestine and rectum and in postoperative complications after resection of the large intestine and rectum].
Topics: Abdominal Abscess; Adult; Aged; beta-Lactamase Inhibitors; Drug Therapy, Combination; Female; Humans; Intestinal Perforation; Intestine, Large; Male; Middle Aged; Penicillanic Acid; Penicillins; Peritonitis; Piperacillin; Postoperative Complications; Rectal Diseases; Retrospective Studies; Surgical Wound Dehiscence; Tazobactam | 2002 |
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock.
Topics: Animals; Antimicrobial Cationic Peptides; Cecum; Disease Models, Animal; Drug Therapy, Combination; Escherichia coli Infections; Ligation; Lipopolysaccharides; Male; Microbial Sensitivity Tests; Peptides; Peritonitis; Piperacillin; Proteins; Punctures; Rats; Rats, Wistar; Shock, Septic | 2003 |
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models.
Topics: Abdomen; Amino Acid Sequence; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cecum; Colony Count, Microbial; Endotoxins; Escherichia coli; Escherichia coli Infections; Injections, Intraperitoneal; Male; Microbial Sensitivity Tests; Penicillins; Peritonitis; Piperacillin; Rats; Rats, Wistar; Sepsis; Shock, Septic; Tumor Necrosis Factor-alpha | 2004 |
Pharmacodynamic modeling of beta-lactam antibiotics for the empiric treatment of secondary peritonitis: a report from the OPTAMA program.
Topics: Anti-Bacterial Agents; beta-Lactams; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 2005 |
Efficiency of tazobactam/piperacillin in lethal peritonitis is enhanced after preconditioning of rats with O3/O2-pneumoperitoneum.
Topics: Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Enzyme Inhibitors; Interleukin-1; Male; Ozone; Penicillanic Acid; Peritonitis; Piperacillin; Pneumoperitoneum; Rats; Rats, Wistar; Tazobactam; Tumor Necrosis Factor-alpha | 2006 |
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.
Topics: Animals; Anti-Infective Agents; Antimicrobial Cationic Peptides; beta-Lactams; Disease Models, Animal; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Lipopolysaccharides; Male; Microbial Sensitivity Tests; Peritonitis; Piperacillin; Proteins; Rats; Rats, Wistar; Shock, Septic | 2006 |
Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Disease Models, Animal; DNA-Binding Proteins; Drug Synergism; Enterococcus faecalis; Escherichia coli; Granulocyte Colony-Stimulating Factor; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Peptides, Cyclic; Peritonitis; Piperacillin; Survival Rate; Tazobactam; Time Factors | 2008 |
Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.
Topics: Animals; Anti-Infective Agents; Antimicrobial Cationic Peptides; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gram-Positive Bacterial Infections; Male; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Rats; Rats, Wistar; Shock, Septic; Tazobactam; Treatment Outcome | 2008 |
Piperacillin in paediatric surgery.
Topics: Abscess; Adolescent; Appendicitis; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Penicillins; Peritonitis; Piperacillin; Postoperative Complications; Urinary Tract Infections | 1982 |
[Fundamental and clinical studies of piperacillin in the field of obstetrics and gynecology].
Topics: Adult; Anti-Bacterial Agents; Female; Humans; Middle Aged; Ovarian Diseases; Pelvic Inflammatory Disease; Penicillins; Peritonitis; Piperacillin; Uterus | 1982 |
Intra-abdominal infection: microbiological and clinical aspects, with special reference to piperacillin prophylaxis and therapy.
Topics: Abscess; Animals; Bacterial Infections; Bacteriological Techniques; Biliary Tract Surgical Procedures; Digestive System; Digestive System Surgical Procedures; Disease Models, Animal; Drainage; Humans; Peritonitis; Piperacillin; Premedication; Rats; Surgical Wound Infection | 1984 |
[Piperacillin, a new penicillin].
Topics: Drug Tolerance; Humans; Penicillin Resistance; Penicillins; Peritonitis; Piperacillin; Pseudomonas Infections; Tissue Distribution | 1981 |
In vitro microbiology and pharmacokinetics of piperacillin.
Topics: Adult; Bacterial Infections; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Infusions, Parenteral; Microbial Sensitivity Tests; Peritonitis; Piperacillin | 1984 |
Directed and non-directed treatment of abdominal infections.
Topics: Abdomen; Anti-Bacterial Agents; Azlocillin; Bacteria; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Peritonitis; Piperacillin | 1984 |
Comparative study of parenteral piperacillin and cefoxitin in the treatment of surgical infections of the abdomen.
Topics: Abdomen; Abdominal Injuries; Adolescent; Adult; Aged; Cefoxitin; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Peritonitis; Piperacillin; Surgical Wound Infection | 1983 |
Group B streptococcus and treatment of CAPD peritonitis.
Topics: Adult; Cephalothin; Drug Therapy, Combination; Glomerulonephritis, Membranous; Humans; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Piperacillin; Rifampin; Streptococcal Infections; Streptococcus agalactiae | 1995 |
An open, multicenter clinical trial of piperacillin/tazobactam in the treatment of pediatric patients with intra-abdominal infections.
Topics: Bacteria, Aerobic; Child; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Infant; Male; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination | 1996 |
Effect of pentaglobin and piperacillin on survival in a rat model of faecal peritonitis: importance of intervention timings.
Topics: Animals; Feces; Immunoglobulin A; Immunoglobulin M; Immunoglobulins, Intravenous; Male; Penicillins; Peritonitis; Piperacillin; Rats; Rats, Sprague-Dawley; Survival Rate; Time Factors | 2000 |
Peritonitis in automated peritoneal dialysis: antibiotic therapy and pharmacokinetics.
Topics: Anti-Bacterial Agents; Cefazolin; Cephalosporins; Female; Humans; Injections, Intraperitoneal; Injections, Intravenous; Male; Penicillins; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Piperacillin; Tobramycin | 2001 |
Simulation of human serum pharmacokinetics of cefazolin, piperacillin, and BRL 42715 in rats and efficacy against experimental intraperitoneal infections.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Biological Availability; Cefazolin; Drug Therapy, Combination; Escherichia coli Infections; Humans; Infusions, Intravenous; Lactams; Male; Microbial Sensitivity Tests; Peritonitis; Piperacillin; Rats; Rats, Inbred Strains; Serratia Infections | 1992 |
Cure of persistent Pseudomonas peritonitis after prolonged antibiotic administration in CAPD patients.
Topics: Adult; Aged; Ceftazidime; Drug Therapy, Combination; Gentamicins; Humans; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Piperacillin; Pseudomonas Infections; Time Factors | 1991 |
Pharmacokinetics of piperacillin in patients on peritoneal dialysis with and without peritonitis.
Topics: Adult; Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Injections, Intraperitoneal; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Piperacillin | 1990 |
A new model of bacterial peritonitis in mice for evaluation of antibiotics. Effects of aspoxicillin and piperacillin.
Topics: Amoxicillin; Ampicillin Resistance; Animals; Ascitic Fluid; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Male; Mice; Peritonitis; Piperacillin | 1989 |
[Effectiveness of piperacillin in the antibacterial treatment of intra-abdominal infections in children].
Topics: Abscess; Adolescent; Appendicitis; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Male; Peritoneal Diseases; Peritonitis; Piperacillin | 1986 |
[Synergistic activity of isepamicin and beta-lactam antibiotics against Pseudomonas aeruginosa in vitro and in vivo].
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Drug Synergism; Drug Therapy, Combination; Gentamicins; Male; Mice; Mice, Inbred ICR; Peritonitis; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections | 1988 |
[Effectiveness of various immunoglobulin preparations administered by the intravenous route in peritonitis in the rat model].
Topics: Animals; Bacterial Infections; Combined Modality Therapy; Gentamicins; Immunoglobulin G; Infusions, Intravenous; Infusions, Parenteral; Peritonitis; Piperacillin; Rats | 1987 |
[Piperacillin in the treatment of spontaneous peritonitis in hepatic cirrhosis].
Topics: Humans; Liver Cirrhosis; Peritonitis; Piperacillin | 1986 |
[Effects and side effects of taurolin in experimental peritonitis in the rat].
Topics: Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Gentamicins; Male; Peritonitis; Piperacillin; Rats; Rats, Inbred Strains; Taurine; Thiadiazines; Thiazines | 1986 |
Comparative activities of piperacillin, ceftazidime, and amikacin, alone and in all possible combinations, against experimental Pseudomonas aeruginosa infections in neutropenic rats.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Neutropenia; Penicillin Resistance; Peritonitis; Piperacillin; Pseudomonas Infections; Rats; Rats, Inbred Strains; Sepsis | 1985 |